Diane V. Lefley

1.3k total citations
23 papers, 1.1k citations indexed

About

Diane V. Lefley is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Diane V. Lefley has authored 23 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Oncology, 9 papers in Molecular Biology and 6 papers in Cancer Research. Recurrent topics in Diane V. Lefley's work include Bone health and treatments (10 papers), Radiopharmaceutical Chemistry and Applications (5 papers) and Cancer Cells and Metastasis (4 papers). Diane V. Lefley is often cited by papers focused on Bone health and treatments (10 papers), Radiopharmaceutical Chemistry and Applications (5 papers) and Cancer Cells and Metastasis (4 papers). Diane V. Lefley collaborates with scholars based in United Kingdom, Finland and United States. Diane V. Lefley's co-authors include Ingunn Holen, Penelope D. Ottewell, Robert E. Coleman, Hannu Mönkkönen, Mark Jones, Steven M.J. Bradbury, Rob Coleman, Catherine A. Evans, Sheila Francis and Claudia Tulotta and has published in prestigious journals such as Nature Communications, PLoS ONE and JNCI Journal of the National Cancer Institute.

In The Last Decade

Diane V. Lefley

21 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Diane V. Lefley United Kingdom 14 706 434 237 204 188 23 1.1k
Hannah K. Brown United Kingdom 21 749 1.1× 526 1.2× 177 0.7× 336 1.6× 355 1.9× 24 1.3k
Akeila Bellahcène Belgium 17 536 0.8× 533 1.2× 145 0.6× 174 0.9× 223 1.2× 22 1.1k
Theresa Guise United States 4 667 0.9× 596 1.4× 113 0.5× 179 0.9× 138 0.7× 5 980
Jinhui Liao United States 14 415 0.6× 444 1.0× 58 0.2× 148 0.7× 104 0.6× 22 872
Nadège Gaborit France 18 449 0.6× 370 0.9× 264 1.1× 156 0.8× 65 0.3× 24 773
Shuaishuai Xu China 17 460 0.7× 294 0.7× 130 0.5× 168 0.8× 189 1.0× 34 1.1k
Chris K. Neeley United States 12 467 0.7× 281 0.6× 57 0.2× 188 0.9× 132 0.7× 13 849
D. Fan United States 14 359 0.5× 404 0.9× 128 0.5× 168 0.8× 119 0.6× 23 804
Kalyan C. Nannuru United States 16 494 0.7× 376 0.9× 45 0.2× 95 0.5× 190 1.0× 20 886

Countries citing papers authored by Diane V. Lefley

Since Specialization
Citations

This map shows the geographic impact of Diane V. Lefley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Diane V. Lefley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Diane V. Lefley more than expected).

Fields of papers citing papers by Diane V. Lefley

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Diane V. Lefley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Diane V. Lefley. The network helps show where Diane V. Lefley may publish in the future.

Co-authorship network of co-authors of Diane V. Lefley

This figure shows the co-authorship network connecting the top 25 collaborators of Diane V. Lefley. A scholar is included among the top collaborators of Diane V. Lefley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Diane V. Lefley. Diane V. Lefley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Murphy, Jessica, et al.. (2022). Novel Methods of Targeting IL-1 Signalling for the Treatment of Breast Cancer Bone Metastasis. Cancers. 14(19). 4816–4816. 9 indexed citations
3.
Tulotta, Claudia, Diane V. Lefley, Russell Hughes, et al.. (2021). IL-1B drives opposing responses in primary tumours and bone metastases; harnessing combination therapies to improve outcome in breast cancer. npj Breast Cancer. 7(1). 95–95. 38 indexed citations
4.
Lefley, Diane V., et al.. (2021). Oestradiol Contributes to Differential Antitumour Effects of Adjuvant Zoledronic Acid Observed Between Pre- and Post-Menopausal Women. Frontiers in Endocrinology. 12. 749428–749428. 3 indexed citations
5.
Tulotta, Claudia, Diane V. Lefley, Walter M. Gregory, et al.. (2019). Endogenous Production of IL1B by Breast Cancer Cells Drives Metastasis and Colonization of the Bone Microenvironment. Clinical Cancer Research. 25(9). 2769–2782. 136 indexed citations
6.
7.
Bishop, Ryan T., Silvia Marino, Diane V. Lefley, et al.. (2019). Pharmacological inhibition of the IKKε/TBK-1 axis potentiates the anti-tumour and anti-metastatic effects of Docetaxel in mouse models of breast cancer. Cancer Letters. 450. 76–87. 19 indexed citations
8.
Lefley, Diane V., Steven M.J. Bradbury, Hannah Brown, et al.. (2019). Development of clinically relevant in vivo metastasis models using human bone discs and breast cancer patient-derived xenografts. Breast Cancer Research. 21(1). 130–130. 35 indexed citations
9.
Eyre, Rachel, Denis Alférez, Angélica Santiago-Gómez, et al.. (2019). Microenvironmental IL1β promotes breast cancer metastatic colonisation in the bone via activation of Wnt signalling. Nature Communications. 10(1). 5016–5016. 115 indexed citations
10.
English, William, Sarah Jane Lunt, Matthew Fisher, et al.. (2017). Differential Expression of VEGFA Isoforms Regulates Metastasis and Response to Anti-VEGFA Therapy in Sarcoma. Cancer Research. 77(10). 2633–2646. 28 indexed citations
11.
Holen, Ingunn, Diane V. Lefley, Sheila Francis, et al.. (2016). IL-1 drives breast cancer growth and bone metastasisin vivo. Oncotarget. 7(46). 75571–75584. 164 indexed citations
12.
Kanthou, Chryso, Gabi U. Dachs, Diane V. Lefley, et al.. (2014). Tumour Cells Expressing Single VEGF Isoforms Display Distinct Growth, Survival and Migration Characteristics. PLoS ONE. 9(8). e104015–e104015. 12 indexed citations
13.
Holen, Ingunn, Faith Nutter, Hannah K. Brown, et al.. (2012). Loss of plakoglobin promotes decreased cell-cell contact, increased invasion, and breast cancer cell dissemination in vivo. Breast Cancer Research. 14(3). R86–R86. 43 indexed citations
14.
Michailidou, Maria, Hannah K. Brown, Diane V. Lefley, et al.. (2010). Microvascular Endothelial Cell Responses in vitro and in vivo: Modulation by Zoledronic Acid and Paclitaxel?. Journal of Vascular Research. 47(6). 481–493. 36 indexed citations
15.
Ottewell, Penelope D., Diane V. Lefley, Simon S. Cross, et al.. (2009). Sustained inhibition of tumor growth and prolonged survival following sequential administration of doxorubicin and zoledronic acid in a breast cancer model. International Journal of Cancer. 126(2). 522–532. 64 indexed citations
16.
Evans, Catherine A., et al.. (2009). Increased anti-tumour effects of doxorubicin and zoledronic acid in prostate cancer cells in vitro: supporting the benefits of combination therapy. Cancer Chemotherapy and Pharmacology. 65(5). 969–978. 23 indexed citations
17.
Ottewell, Penelope D., Julia K. L. Woodward, Diane V. Lefley, et al.. (2009). Anticancer mechanisms of doxorubicin and zoledronic acid in breast cancer tumor growth in bone. Molecular Cancer Therapeutics. 8(10). 2821–2832. 67 indexed citations
18.
Mönkkönen, Hannu, Ingunn Holen, Diane V. Lefley, et al.. (2008). Bisphosphonate-induced ATP analog formation and its effect on inhibition of cancer cell growth. Anti-Cancer Drugs. 19(4). 391–399. 63 indexed citations
19.
Ottewell, Penelope D., Hannu Mönkkönen, Mark Jones, et al.. (2008). Antitumor Effects of Doxorubicin Followed by Zoledronic Acid in a Mouse Model of Breast Cancer. JNCI Journal of the National Cancer Institute. 100(16). 1167–1178. 187 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hannah K. Brown Breakdown of academic impact, for papers by Akeila Bellahcène Breakdown of academic impact, for papers by Theresa Guise Breakdown of academic impact, for papers by Jinhui Liao Breakdown of academic impact, for papers by Nadège Gaborit Breakdown of academic impact, for papers by Shuaishuai Xu Breakdown of academic impact, for papers by Chris K. Neeley Breakdown of academic impact, for papers by D. Fan Breakdown of academic impact, for papers by Kalyan C. Nannuru
Rankless by CCL
2026